SEC Form 4 · accession 0000313143-15-000022
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J Lindop
Officer — CFO & EVP Business Development
Period of report
Apr 20, 2015
Accepted (ET)
Apr 22, 2015 · 2:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 20, 2015 | M | 4,902 | $26.315 | A | 42,735 | D | |
| Common StockF1 | Apr 20, 2015 | S | 4,902 | $41.5496 | D | 37,833 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1,F2 | $26.315 | Apr 20, 2015 | M | 4,902 | D | Oct 23, 2009 | Oct 23, 2015 | Common Stock | 4,902 | 19,608 | D |
Explanation of responses
- F1Pursuant to a 10b5-1 Plan.
- F2Grant to reporting person of right to buy shares of common stock vesting in annual increments over a 5 year period beginning on the first anniversary of the date of grant.